Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $99.60 | 3 | 52.6% |
| Food and Beverage | $89.79 | 5 | 47.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Exelixis Inc. | $55.00 | 1 | $0 (2019) |
| PFIZER INC. | $44.60 | 2 | $0 (2023) |
| Pharmacyclics LLC, An AbbVie Company | $22.80 | 1 | $0 (2018) |
| Ipsen Biopharmaceuticals, Inc | $21.13 | 1 | $0 (2024) |
| EMD Serono, Inc. | $16.58 | 1 | $0 (2018) |
| Astellas Pharma US Inc | $15.11 | 1 | $0 (2018) |
| EISAI INC. | $14.17 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $21.13 | 1 | Ipsen Biopharmaceuticals, Inc ($21.13) |
| 2023 | $44.60 | 2 | PFIZER INC. ($44.60) |
| 2019 | $69.17 | 2 | Exelixis Inc. ($55.00) |
| 2018 | $54.49 | 3 | Pharmacyclics LLC, An AbbVie Company ($22.80) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/06/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: Rare Disease | ||||||
| 06/08/2023 | PFIZER INC. | IBRANCE (Drug) | Education | In-kind items and services | $31.80 | General |
| Category: ONCOLOGY | ||||||
| 06/08/2023 | PFIZER INC. | IBRANCE (Drug) | Education | In-kind items and services | $12.80 | General |
| Category: ONCOLOGY | ||||||
| 11/18/2019 | EISAI INC. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $14.17 | General |
| Category: Oncology | ||||||
| 09/19/2019 | Exelixis Inc. | Cabometyx (Drug) | Education | In-kind items and services | $55.00 | General |
| Category: Oncology | ||||||
| 09/10/2018 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: ONCOLOGY | ||||||
| 04/23/2018 | EMD Serono, Inc. | Bavencio (Biological) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: Oncology | ||||||
| 02/14/2018 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: Oncology | ||||||
About Dr. Khader Hussein, M.D
Dr. Khader Hussein, M.D is a Hematology & Oncology healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1285685982.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Khader Hussein, M.D has received a total of $189.39 in payments from pharmaceutical and medical device companies, with $21.13 received in 2024. These payments were reported across 8 transactions from 7 companies. The most common payment nature is "Education" ($99.60).
Practice Information
- Specialty Hematology & Oncology
- Location Oklahoma City, OK
- Active Since 05/15/2006
- Last Updated 07/13/2017
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1285685982
Products in Payments
- Cabometyx (Drug) $55.00
- IBRANCE (Drug) $44.60
- Imbruvica (Drug) $22.80
- IQIRVO (Drug) $21.13
- Bavencio (Biological) $16.58
- XTANDI (Drug) $15.11
- Lenvima (Drug) $14.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Oklahoma City
Robert Reynolds, Md, MD
Hematology & Oncology — Payments: $14,579
Philip Comp, Md, MD
Hematology & Oncology — Payments: $13,151
Dr. Charles Hollen, M.d, M.D
Hematology & Oncology — Payments: $12,135
Jennifer Holter-Chakrabarty, Md, MD
Hematology & Oncology — Payments: $11,994
Dr. Saadia Chohan, Md, MD
Hematology & Oncology — Payments: $11,197
Abby Bova, Md, MD
Hematology & Oncology — Payments: $5,791